<DOC>
	<DOCNO>NCT00723190</DOCNO>
	<brief_summary>The purpose 12-month , multi-center , open-label study evaluate safety CLONICEL ( clonidine HCl sustain release ) administer chronically regular clinical condition either monotherapy combination stimulant therapy child adolescent attention deficit hyperactivity disorder ( ADHD ) .</brief_summary>
	<brief_title>Open-Label , Chronic Exposure , Safety Study CLONICEL ( Clonidine HCl Sustained Release ) Children Adolescents With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Male female subject complete either study CLON301 study CLON302 , discontinue early reason adverse event necessitate discontinuation Age 6 17 year , inclusive Diagnosis attention deficit hyperactivity disorder hyperactive combine inattentive/hyperactive subtypes accord Diagnostic Statistical Manual Mental Disorders IV ( DSM IV ) criteria General good health judge Principal Investigator Body mass index ( BMI ) â‰¥ 5th percentile subject 's age group accord CDC growth chart . BMI calculate use formula : weight ( kg ) / [ height ( ) ] 2 Subject well parent/guardian able sign inform assent consent form If female childbearing potential , pregnant lactate agree use medically acceptable form birth control , hormonal medication , doublebarrier method , intrauterine device Presence clinically significant illness abnormality physical examination clinical laboratory evaluation , opinion investigator , would increase safety risk clonidine administration interfere ability patient take part study . Presence clinically significant abnormality centrally interpret electrocardiogram reading History presence concomitant psychiatric disorder require psychotropic medication severe concomitant axis I axis II disorder could interfere study assessment judgment Principal Investigator Presence disorder would interfere absorption , metabolism , excretion clonidine Presence alcohol drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>CLONICEL</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>clonidine HCl sustain release</keyword>
</DOC>